Korean Post-marketing Surveillance for Xeljanz

Clinical trial NCT02984020 · COMPLETED

Trial details

NCT number: NCT02984020
Sponsor: Pfizer
Status: COMPLETED
Study type: OBSERVATIONAL

Rheumatoid Arthritis Psoriatic Arthritis

Start date: 2016-05-13
Primary completion: 2022-06-09
Enrollment: 1041

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.